Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Expert Opinion on Drug Safety|October 14, 2024
Drug-induced myocarditis: a real-world pharmacovigilance study using the FDA adverse event reporting system databaseYunxiang Zhong, Zhiping Li, Jinyi Tao, et al.Cancer Control : Journal of the Moffitt Cancer Center|May 16, 2026
Gender Differences in EGFR-TKI-Related Adverse Events: A Pharmacovigilance Study Based on the FAERS DatabaseShuman Wang, Tingting Wu, Yajing Liu, et al.Expert Opinion on Drug Safety|May 13, 2024
Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance studyGuixiang Chen, Li Zhang, Si-Ting Zhao, et al.Acta Pharmaceutica Sinica. B|January 14, 2025
AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancerZhiwen Fu, Tingting Wu, Chen Gao, et al.Biomedical Chromatography : BMC|October 15, 2013
HPLC-Q-TOF-MS/MS for analysis of major chemical constituents of Yinchen-Zhizi herb pair extractZhiwen Fu, Yun Ling, Zhixiong Li, et al.BMC Cancer|November 18, 2025
Unraveling gut microbiome interferences in cancer immunotherapy: a meta-analysis of diverse drug effectsJiaqiang Xu, Jingling Song, Zhiwen Fu, et al.BMC Pharmacology & Toxicology|February 7, 2025
The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) databaseHuiping Hu, Maochang Liu, Zhiwen Fu, et al.Gynecologic Oncology|January 31, 2024
Hypertension associated with niraparib in cancer patients: A pharmacovigilance analysis based on the FAERS database and meta-analysis of randomized controlled trialsWei Chen, Jiyi Xie, Chen Gao, et al.The European Journal of Neuroscience|September 12, 2014
Burst-firing patterns in the prefrontal cortex underlying the neuronal mechanisms of depression probed by antidepressantsFei Guo, Qi Zhang, Bing Zhang, et al.Frontiers in Pharmacology|July 8, 2025
Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysisCong Zhang, Zhiwen Fu, Jinmei Liu, et al.Pageof 5